Eurythmy Therapy for Dry Mouth

Erdmuthe Worel, Eurythmy Therapy Team Klinik Arlesheim, Andreas Worel

Last update: 14.08.2019

The therapeutic aim in the treatment of dry mouth is to stimulate the etheric body through exercises that specifically affect the fluid organism. Additional appropriate movements enable the soul body and ‘I’-organization to better reconnect with the etheric body, stimulating glandular activity.

Therapeutic recommendations

  • “M” and “L” in a rocking step  
    A rocking step with “M” and “L” stimulates the etheric body which is active in the fluid organism.
    The gestures for “M” and “L” can also be done with the feet, standing or sitting. Stimulating rhythms such as iamb and anapest set the fluid organism in motion.

  • The sound “R”
    The ‘air sound’ “R” sets the soul body in motion and strengthens its connection with the physical and etheric bodies, thereby stimulating glandular activity.

  • “CH” and “F” or “W” in alternation
    Sounds such as “CH” and either “F” or “W” in alternation connect the front with the back space as in a wave. They stimulate the flow of body fluids, also counteracting the feelings of constriction through their gesture of widening.
    In bedridden patients, we can guide “CH” alternately with “F” or “W” around the mouth or from the mouth to the periphery, as this diverts or eases the experienced fixation on the problem.

  • Direct “H” into a widening “A” and ebb down with “SCH”.

  • Hands and feet in motion
    Moving the hands and feet, either actively or passively by the eurythmy therapist, has a relaxing effect. It stimulates the etheric body in the fluid organism.

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine